Alligator Bioscience AB
STO:ATORX

Watchlist Manager
Alligator Bioscience AB Logo
Alligator Bioscience AB
STO:ATORX
Watchlist
Price: 4.0505 SEK -4.02%
Market Cap: 125.1m SEK

Relative Value

The Relative Value of one ATORX stock under the Base Case scenario is 20.3482 SEK. Compared to the current market price of 4.0505 SEK, Alligator Bioscience AB is Undervalued by 80%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATORX Relative Value
Base Case
20.3482 SEK
Undervaluation 80%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
75
Median 3Y
471.3
Median 5Y
113.4
Industry
6.9
Forward
1.1
vs History
vs Industry
Median 3Y
-102.6
Median 5Y
-138.7
Industry
23
Forward
-89.8
vs History
vs Industry
Median 3Y
-123.1
Median 5Y
-155.4
Industry
19.7
vs History
vs Industry
Median 3Y
-115.4
Median 5Y
-147.7
Industry
22.8
vs History
vs Industry
0
Median 3Y
102.8
Median 5Y
176.4
Industry
2.6
vs History
95
vs Industry
68
Median 3Y
470.5
Median 5Y
112.7
Industry
7.4
Forward
1.1
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.3
vs History
vs Industry
Median 3Y
-107.5
Median 5Y
-148.1
Industry
4.1
Forward
-2
vs History
vs Industry
Median 3Y
-101.1
Median 5Y
-139
Industry
4.1
Forward
-1.8
vs History
vs Industry
Median 3Y
-122.5
Median 5Y
-154.9
Industry
4.9
vs History
vs Industry
Median 3Y
-120.8
Median 5Y
-154.5
Industry
3.6
vs History
95
vs Industry
40
Median 3Y
387.5
Median 5Y
490.4
Industry
4.7

Multiples Across Competitors

ATORX Competitors Multiples
Alligator Bioscience AB Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Alligator Bioscience AB
STO:ATORX
125.1m SEK 2.5 -0.7 -0.8 -0.6
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 726 477.3 -165 049.8 -200 423.1 -198 136
US
Abbvie Inc
NYSE:ABBV
330.9B USD 5.8 79.6 15.2 22.4
US
Amgen Inc
NASDAQ:AMGN
154.3B USD 4.5 26 14.1 23.2
US
Gilead Sciences Inc
NASDAQ:GILD
135.7B USD 4.7 22.8 9.9 13.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
114.6B USD 10.3 -115.9 24.6 25.8
US
Epizyme Inc
F:EPE
94.1B EUR 2 028.7 -517.7 -563.7 -548.7
AU
CSL Ltd
ASX:CSL
117.6B AUD 5 27.8 17.2 21.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
52.5B USD 3.7 11.7 10.3 11.5
US
Seagen Inc
F:SGT
39.3B EUR 19.5 -59.9 -64.6 -58.2
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
39.8B USD 16.9 -147.5 -660.4 -330.9
P/E Multiple
Earnings Growth PEG
SE
Alligator Bioscience AB
STO:ATORX
Average P/E: 33.6
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -165 049.8 N/A N/A
US
Abbvie Inc
NYSE:ABBV
79.6
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.8
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -115.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -517.7 N/A N/A
AU
CSL Ltd
ASX:CSL
27.8
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.7
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -59.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -147.5 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Alligator Bioscience AB
STO:ATORX
Average EV/EBITDA: 15.2
Negative Multiple: -0.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -200 423.1 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.2
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.1
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.9
6%
1.7
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.6
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -563.7 N/A N/A
AU
CSL Ltd
ASX:CSL
17.2
11%
1.6
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.3
11%
0.9
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -660.4 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Alligator Bioscience AB
STO:ATORX
Average EV/EBIT: 19.7
Negative Multiple: -0.6
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -198 136 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.4
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.2
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.7
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.8
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -548.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.5
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
11.5
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.2 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -330.9 N/A N/A